Wilson disease
Autosomal recessive ATP7B defect → copper accumulates in liver, brain, cornea. Consider in any unexplained liver disease (age alone doesn’t exclude it), liver disease with neuropsychiatric features, and acute liver failure with Coombs-negative haemolysis (→ urgent transplant). Diagnose by combining ceruloplasmin, 24-h urine copper, slit-lamp and, if needed, hepatic copper or ATP7B genotyping (Leipzig score). Symptomatic → chelator (trientine better tolerated than penicillamine); asymptomatic or maintenance → chelator or zinc. Lifelong.
when to suspect
- unexplained liver enzyme abnormality, steatosis or cirrhosis — any age (mostly 3–55)
- liver disease + movement disorder, dysarthria, or psychiatric change
- acute liver failure with Coombs-negative haemolysis → urgent transplant evaluation
- recurrent unexplained non-immune haemolysis
- first-degree relative with Wilson disease (screen siblings)
- looks like autoimmune hepatitis (ANA and IgG can be positive) → check ceruloplasmin
diagnosis
No single test is enough; combine them (Leipzig score ≥4 = diagnosis).
| test | Wilson | caveats |
|---|---|---|
| ceruloplasmin | low; <0.05 g/L strongly suggestive | modestly low in heterozygotes, malnutrition, protein loss; normal level doesn’t exclude (acute-phase reactant) |
| 24-h urine copper | >1.6 µmol/day symptomatic; >0.6 µmol/day warrants work-up | |
| slit lamp | Kayser–Fleischer rings | often absent in hepatic-only disease; nearly always present with neurological disease |
| liver biopsy | hepatic copper; histology and staging | |
| ATP7B genotyping | two pathogenic variants confirm | |
| brain MRI | if neurological features |
Wilsonian acute liver failure clues: Coombs-negative haemolysis, very high bilirubin with low ALP (ALP:bilirubin ratio <4), AST:ALT >2.2, low uric acid.
treatment
| phase | options |
|---|---|
| symptomatic, initial | chelator: trientine (better tolerated) or D-penicillamine |
| asymptomatic | lower-dose chelator or zinc |
| maintenance (after ≥1 year with good response) | lower-dose chelator or full-dose zinc (50 mg elemental TID in adults) |
| acute liver failure | liver transplant — chelation alone is insufficient; no Wilson treatment needed after transplant |
- Zinc blocks intestinal copper absorption (induces enterocyte metallothionein); chelators increase urinary copper excretion.
- Neurological disease can worsen early on chelation, especially penicillamine — start low, involve neurology.
- Penicillamine toxicity: hypersensitivity, marrow suppression, proteinuria/nephrotic syndrome, lupus-like syndrome → many switch to trientine.
- Avoid high-copper foods (shellfish, organ meats, nuts, chocolate) during initial therapy.
- Monitor: liver enzymes, CBC, urinalysis; 24-h urine copper on chelators (~3–8 µmol/day on stable treatment) or zinc (low copper, high zinc). Very low urinary copper → overtreatment (copper deficiency: anaemia, neutropenia, myelopathy).
- Never stop — non-adherence causes fatal liver failure. Continue through pregnancy (dose-reduce chelators).
- Cirrhosis → HCC surveillance (hepatocellular carcinoma).
Prepared 2026-10-28. Not yet verified — check every number against the sources.